These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 35972732)

  • 1. Monitoring Therapeutic Response to Anti-FAP CAR T Cells Using [18F]AlF-FAPI-74.
    Lee IK; Noguera-Ortega E; Xiao Z; Todd L; Scholler J; Song D; Liousia M; Lohith K; Xu K; Edwards KJ; Farwell MD; June CH; Albelda SM; Puré E; Sellmyer MA
    Clin Cancer Res; 2022 Dec; 28(24):5330-5342. PubMed ID: 35972732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation and pilot clinical study of [
    Ge L; Fu Z; Wei Y; Shi D; Geng Y; Fan H; Zhang R; Zhang Y; Li S; Wang S; Shi H; Song G; Pan J; Cheng K; Wang L
    Eur J Nucl Med Mol Imaging; 2022 Oct; 49(12):4025-4036. PubMed ID: 35715613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Visualization of Activated Fibroblasts in Heart Failure with Preserved Ejection Fraction with [
    Sun F; Wang C; Feng H; Yu F; Zhang X; Zhang P; Du X
    Mol Pharm; 2023 May; 20(5):2634-2641. PubMed ID: 37043243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting Fibroblast Activation Protein: Radiosynthesis and Preclinical Evaluation of an
    Toms J; Kogler J; Maschauer S; Daniel C; Schmidkonz C; Kuwert T; Prante O
    J Nucl Med; 2020 Dec; 61(12):1806-1813. PubMed ID: 32332144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
    Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
    Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [
    Wei Y; Cheng K; Fu Z; Zheng J; Mu Z; Zhao C; Liu X; Wang S; Yu J; Yuan S
    Eur J Nucl Med Mol Imaging; 2022 Apr; 49(5):1671-1681. PubMed ID: 34870727
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development of Fibroblast Activation Protein-Targeted Radiotracers with Improved Tumor Retention.
    Loktev A; Lindner T; Burger EM; Altmann A; Giesel F; Kratochwil C; Debus J; Marmé F; Jäger D; Mier W; Haberkorn U
    J Nucl Med; 2019 Oct; 60(10):1421-1429. PubMed ID: 30850501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma:
    Watabe T; Liu Y; Kaneda-Nakashima K; Shirakami Y; Lindner T; Ooe K; Toyoshima A; Nagata K; Shimosegawa E; Haberkorn U; Kratochwil C; Shinohara A; Giesel F; Hatazawa J
    J Nucl Med; 2020 Apr; 61(4):563-569. PubMed ID: 31586001
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Lindner T; Altmann A; Giesel F; Kratochwil C; Kleist C; Krämer S; Mier W; Cardinale J; Kauczor HU; Jäger D; Debus J; Haberkorn U
    EJNMMI Radiopharm Chem; 2021 Aug; 6(1):26. PubMed ID: 34417894
    [TBL] [Abstract][Full Text] [Related]  

  • 10.
    Giesel FL; Kratochwil C; Lindner T; Marschalek MM; Loktev A; Lehnert W; Debus J; Jäger D; Flechsig P; Altmann A; Mier W; Haberkorn U
    J Nucl Med; 2019 Mar; 60(3):386-392. PubMed ID: 30072500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibroblast Activation Protein Targeting Probe with Gly-Pro Sequence for PET of Glioblastoma.
    Lai C; Cao R; Li R; He C; Wang X; Shi H; Qu C; Qian K; Song S; Chen WH; Cheng Z
    Mol Pharm; 2023 Aug; 20(8):4120-4128. PubMed ID: 37487027
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and preclinical evaluation of novel
    Zhou H; Zhong J; Peng S; Liu Y; Tang P; Cai Z; Wang L; Xu H; Hu K
    Eur J Med Chem; 2024 Jan; 264():115993. PubMed ID: 38039792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and Development of
    Lindner T; Altmann A; Krämer S; Kleist C; Loktev A; Kratochwil C; Giesel F; Mier W; Marme F; Debus J; Haberkorn U
    J Nucl Med; 2020 Oct; 61(10):1507-1513. PubMed ID: 32169911
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Application of [
    Zhang H; An J; Wu P; Zhang C; Zhao Y; Tan D; Shi C; Ge X
    Contrast Media Mol Imaging; 2022; 2022():6596702. PubMed ID: 36051919
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical evaluation and pilot clinical study of [
    Hu K; Li J; Wang L; Huang Y; Li L; Ye S; Han Y; Huang S; Wu H; Su J; Tang G
    Acta Pharm Sin B; 2022 Feb; 12(2):867-875. PubMed ID: 35256951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [
    Wei Y; Zheng J; Ma L; Liu X; Xu S; Wang S; Pei J; Cheng K; Yuan S; Yu J
    Eur J Nucl Med Mol Imaging; 2022 Jul; 49(8):2761-2773. PubMed ID: 35262766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting fibroblast activation protein in tumor stroma with chimeric antigen receptor T cells can inhibit tumor growth and augment host immunity without severe toxicity.
    Wang LC; Lo A; Scholler J; Sun J; Majumdar RS; Kapoor V; Antzis M; Cotner CE; Johnson LA; Durham AC; Solomides CC; June CH; Puré E; Albelda SM
    Cancer Immunol Res; 2014 Feb; 2(2):154-66. PubMed ID: 24778279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein.
    Lindner T; Loktev A; Altmann A; Giesel F; Kratochwil C; Debus J; Jäger D; Mier W; Haberkorn U
    J Nucl Med; 2018 Sep; 59(9):1415-1422. PubMed ID: 29626119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of Fibroblast Activation Protein Inhibitor-Based Dimeric Radiotracers with Improved Tumor Retention and Antitumor Efficacy.
    Zhao L; Chen J; Pang Y; Fang J; Fu K; Meng L; Zhang X; Guo Z; Wu H; Sun L; Su G; Lin Q; Chen H
    Mol Pharm; 2022 Oct; 19(10):3640-3651. PubMed ID: 35917335
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From basic research to clinical application: targeting fibroblast activation protein for cancer diagnosis and treatment.
    Zhang Z; Tao J; Qiu J; Cao Z; Huang H; Xiao J; Zhang T
    Cell Oncol (Dordr); 2024 Apr; 47(2):361-381. PubMed ID: 37726505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.